Join Gabriel Otte, CEO of Freenome, Vijay Pande, a general partner at Andreessen Horowitz, and Malinka Walaliyadde, also from Andreessen Horowitz, as they dive into the complexities of genomics and disease. They explore the transition from traditional genome sequencing to machine learning in cancer detection. Tackling the interplay of numerous genes, they discuss the importance of early diagnosis and the role of innovative technologies. Hear insights on how advancements in genomics could redefine healthcare, uncovering previously misunderstood areas of the human genome.
